Skip to main content

Find Clinical Trials

Home
Conditions
Acute Myeloid Leukemia With Gene Mutations

Clinical trial condition

Acute Myeloid Leukemia With Gene Mutations

Explore clinical trials studying Acute Myeloid Leukemia With Gene Mutations. Study availability and eligibility vary by location and protocol.

5 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Acute Myeloid Leukemia With Gene Mutations trial results

Recruiting

Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients

NCT07507760

Conditions: Acute Myeloid Leukemia With Gene Mutations
Locations: Complejo Hospitalario de Albacete Albacete, Spain

Hospital General Universitario Dr. Balmis Alicante, Spain

Hospital Universitario de Burgos Burgos, Spain

Hospital San Pedro Alcántara Cáceres, Spain

View all 15 locations

View Trial Details

Recruiting

CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT04493164

Conditions: Acute Myeloid Leukemia With Gene Mutations, Bone Marrow Diseases, Hematologic Diseases, +12 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine

NCT03588078

Conditions: Acute Myeloid Leukemia With Gene Mutations, Bone Marrow Diseases, Chronic Disease, +15 more
Locations: Bruno Quesnel Lille, France

Dr Pierre Peterlin and Pr Patrice Chevalier Nantes, France

Hôpital Archet 1 Nice, France

Hôpital Saint Louis - Hématologie Séniors Paris, France

View Trial Details

Completed

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

NCT01760655

Conditions: Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM, +61 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

NCT01904136

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Gene Mutations, +26 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details